CAM
RCUS icon

ClariVest Asset Management’s Arcus Biosciences RCUS Stock Holding History

ClariVest Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$260K Hold
17,092
– – 0.03% 372
2024
Q2 		$260K Buy
+17,092
New +$276K 0.03% 372

Other funds holding RCUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClariVest Asset Management's RCUS Position: Q3 2024 in Review

ClariVest Asset Management held its Arcus Biosciences (RCUS) position steady in Q3 2024 at 17,092 shares worth $260K. The position accounts for 0.03% of the portfolio, ranked #372.

ClariVest Asset Management first reported a position in RCUS in Q2 2024 and has held it in 2 quarters since. 187 funds tracked by Wall St. Rank hold RCUS as of Q3 2024.

  • ClariVest Asset Management held 17,092 shares of Arcus Biosciences worth $260K as of Q3 2024.
  • ClariVest Asset Management left its Arcus Biosciences share count unchanged in Q3 2024.
  • Arcus Biosciences made up 0.03% of ClariVest Asset Management's portfolio in Q3 2024, its #372 holding.
  • ClariVest Asset Management first reported a position in Arcus Biosciences in Q2 2024 and has held it in 2 quarters since.
  • 187 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.